0.68 - 0.75
0.33 - 0.86
18.36M / 4.66M (Avg.)
34.50 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
26.24%
Positive revenue growth while 0376.HK is negative. John Neff might see a notable competitive edge here.
9.27%
Positive gross profit growth while 0376.HK is negative. John Neff would see a clear operational edge over the competitor.
-4.45%
Negative EBIT growth while 0376.HK is at 0.00%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-4.45%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
23.51%
Positive net income growth while 0376.HK is negative. John Neff might see a big relative performance advantage.
21.43%
EPS growth above 1.5x 0376.HK's 8.00%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
21.43%
Diluted EPS growth above 1.5x 0376.HK's 7.26%. David Dodd would see if there's a robust moat protecting these shareholder gains.
1.69%
Share reduction more than 1.5x 0376.HK's 141.10%. David Dodd would see if the company is taking advantage of undervaluation to retire shares.
1.59%
Diluted share reduction more than 1.5x 0376.HK's 137.49%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
No Data
No Data available this quarter, please select a different quarter.
19.78%
OCF growth under 50% of 0376.HK's 479.48%. Michael Burry might suspect questionable revenue recognition or rising costs.
25.16%
FCF growth under 50% of 0376.HK's 863.02%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
21014.84%
Positive 10Y revenue/share CAGR while 0376.HK is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
24.65%
Positive 5Y CAGR while 0376.HK is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
-3.39%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
-9466.85%
Negative 10Y OCF/share CAGR while 0376.HK stands at 143.56%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-5313.50%
Negative 5Y OCF/share CAGR while 0376.HK is at 136.19%. Joel Greenblatt would question the firm’s operational model or cost structure.
-1349.92%
Negative 3Y OCF/share CAGR while 0376.HK stands at 159.96%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
23.83%
Below 50% of 0376.HK's 66.74%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
-22.39%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
13.82%
3Y net income/share CAGR 50-75% of 0376.HK's 22.31%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
95.36%
Below 50% of 0376.HK's 304.60%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
40.98%
Below 50% of 0376.HK's 271.96%. Michael Burry suspects a serious short-term disadvantage in building book value.
No Data
No Data available this quarter, please select a different quarter.
93.73%
Dividend/share CAGR of 93.73% while 0376.HK is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
84.64%
3Y dividend/share CAGR of 84.64% while 0376.HK is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
47.11%
AR growth of 47.11% while 0376.HK is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
-21.61%
Inventory is declining while 0376.HK stands at 0.00%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
22.34%
Asset growth above 1.5x 0376.HK's 0.76%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
4.73%
Positive BV/share change while 0376.HK is negative. John Neff sees a clear edge over a competitor losing equity.
1816.96%
Debt growth of 1816.96% while 0376.HK is zero. Bruce Berkowitz sees additional leverage that must yield profitable expansions to be worthwhile.
80.16%
R&D growth of 80.16% while 0376.HK is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
47.97%
SG&A growth well above 0376.HK's 67.45%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.